Integral Diagnostics Ltd
ASX:IDX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.66
3.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IDX stock under the Base Case scenario is 6.22 AUD. Compared to the current market price of 2.9 AUD, Integral Diagnostics Ltd is Undervalued by 53%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Integral Diagnostics Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Integral Diagnostics Ltd
Balance Sheet Decomposition
Integral Diagnostics Ltd
Current Assets | 74.8m |
Cash & Short-Term Investments | 42.4m |
Receivables | 24.8m |
Other Current Assets | 7.6m |
Non-Current Assets | 669.5m |
Long-Term Investments | 5k |
PP&E | 270.4m |
Intangibles | 399.1m |
Current Liabilities | 85.7m |
Accounts Payable | 32.8m |
Other Current Liabilities | 52.9m |
Non-Current Liabilities | 356.9m |
Long-Term Debt | 341.6m |
Other Non-Current Liabilities | 15.3m |
Earnings Waterfall
Integral Diagnostics Ltd
Revenue
|
469.7m
AUD
|
Cost of Revenue
|
-22.9m
AUD
|
Gross Profit
|
446.8m
AUD
|
Operating Expenses
|
-404.6m
AUD
|
Operating Income
|
42.2m
AUD
|
Other Expenses
|
-102.9m
AUD
|
Net Income
|
-60.7m
AUD
|
Free Cash Flow Analysis
Integral Diagnostics Ltd
AUD | |
Free Cash Flow | AUD |
IDX Profitability Score
Profitability Due Diligence
Integral Diagnostics Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Integral Diagnostics Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
IDX Solvency Score
Solvency Due Diligence
Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDX Price Targets Summary
Integral Diagnostics Ltd
According to Wall Street analysts, the average 1-year price target for IDX is 3.21 AUD with a low forecast of 2.53 AUD and a high forecast of 3.9 AUD.
Dividends
Current shareholder yield for IDX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
IDX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one IDX stock under the Base Case scenario is 6.22 AUD.
Compared to the current market price of 2.9 AUD, Integral Diagnostics Ltd is Undervalued by 53%.